In preclinical and animal models, researchers study IGF1-LR3 (Insulin-like Growth Factor-1 Long R3) to evaluate its potent anabolic, mitogenic, and cell-survival signaling pathways. It has gained significant attention in endocrinology and cellular biology as an “extended-half-life” analogue of native IGF-1 because of a structural modification that dramatically reduces its binding affinity to IGF binding proteins (IGFBPs), allowing it to remain active longer, upregulate protein synthesis, and stimulate nutrient partitioning into muscle tissue without rapid deactivation.

Current Areas of Investigation

• Extended receptor signaling and IGFBP resistance dynamics

• Skeletal muscle hyperplasia, hypertrophy, and satellite cell activation

• Akt/mTOR cellular growth and protein translation pathways

• Systemic nutrient partitioning and cellular glucose transport modulation

• Tissue regeneration and cell survival under ischemic or catabolic stress

Research Focus

Technical Specifications

• Appearance: Lyophilized white to off-white cake or powder.

• Storage Requirements: Store desiccated at −20°C for long-term molecular stability, protected from light and moisture; reconstitute under sterile laboratory conditions.

Research Disclaimer: IGF1-LR3 supplied by Nomad Clinical is intended exclusively for laboratory research purposes. It is not approved as a medicinal product or food supplement and is not intended for human or veterinary use. References to published scientific literature are provided for educational context only.